98589-84-5 Usage
Uses
Used in Pharmaceutical Synthesis:
5-nitroquinolin-3-amine is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic properties.
Used in Agrochemical Production:
In the agrochemical industry, 5-nitroquinolin-3-amine is utilized as a building block for the creation of compounds that can be used in pest control and crop protection, enhancing agricultural productivity.
Used in Heterocyclic Compound Preparation:
5-nitroquinolin-3-amine serves as a valuable precursor in the preparation of various heterocyclic compounds, which are important in organic chemistry and have a wide range of applications, including medicinal chemistry.
Used in Antitumor Research:
5-nitroquinolin-3-amine has been studied for its potential antitumor properties, making it a compound of interest in cancer research and drug development.
Used in Antibacterial Applications:
5-nitroquinolin-3-amine has also been investigated for its antibacterial properties, which could lead to the development of new antibiotics to combat resistant bacterial strains.
However, it is crucial to handle 5-nitroquinolin-3-amine with care due to its known hazards to human health and the environment. Proper safety measures should be taken during its synthesis, use, and disposal to minimize potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 98589-84-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,5,8 and 9 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 98589-84:
(7*9)+(6*8)+(5*5)+(4*8)+(3*9)+(2*8)+(1*4)=215
215 % 10 = 5
So 98589-84-5 is a valid CAS Registry Number.
98589-84-5Relevant academic research and scientific papers
Inhibitors of prenyl-protein transferase
-
, (2008/06/13)
The present invention is directed to macrocyclic compounds which inhibit prenyl-protein transferase (FTase) and the prenylation of the oncogene protein Ras. The invention is further directed to chemothera-peutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
